What is the CCNA?
350+ clinicians and researchers throughout Canada have come together to form the CCNA and are accelerating progress in age-related neurodegenerative diseases, including Alzheimer’s disease, Vascular dementia, Frontotemporal dementia, and Lewy body dementia.
Based on their area of specialization, CCNA’s researchers are divided into 20 teams throughout Canada, and are working in the areas of prevention, treatment, and quality of life. They draw on the data of eight national platforms, and are supported by four cross-cutting programs, who assist teams in identifying gaps, synergies, and accelerating idea uptake.
What is the CCNA’s objective?
The CCNA’s combined expertise will be used to strengthen understanding of:
- How these diseases develop
- Their impact on the individual, families, and the community as a whole
- What can be done to slow their progression and cope with them, if not prevent the diseases altogether
By doing this, the CCNA will positively impact the quality of life and the quality of services for individuals living with neurodegenerative diseases.
The CCNA aims to accomplish this by:
- Uniting experts and resources across Canadian universities, hospitals, government, industry and non-profit organizations.
- Providing a critical link between basic science research programs in neurodegenerative diseases and clinical populations.
- Identifying and investing in national priorities, including service delivery challenges, care within different provincial systems, and rural and Indigenous communities.
- Providing specialized training and mentorship to prepare the next generation of researchers, clinician-scientists, policy makers and educators in the areas of neurodegenerative diseases and aging.
- Coordinating and supporting high priority, multidisciplinary research, and knowledge transfer initiatives.
- Forming international collaborations.